Literature DB >> 19061394

Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.

Ranjala Ratnayake1, David Covell, Tanya T Ransom, Kirk R Gustafson, John A Beutler.   

Abstract

An extract from Phyllanthus engleri was identified in a bioinformatic analysis of NCI 60-cell natural product extract screening data that selectively inhibited the growth of renal cancer cell lines. Bioassay-guided fractionation yielded two new guaiane sesquiterpenes, englerins A (1) and B (2). Englerin A showed 1000-fold selectivity against six of eight renal cancer cell lines with GI(50) values ranging from 1-87 nM. The structures of 1 and 2 and their relative stereochemistry were established by spectroscopic methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19061394      PMCID: PMC2651161          DOI: 10.1021/ol802339w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  14 in total

1.  A novel 5-HT receptor ligand and related cytotoxic compounds from an acid mine waste extremophile.

Authors:  Andrea A Stierle; Donald B Stierle; Eric Goldstein; Keith Parker; Tim Bugni; Chad Baarson; Julie Gress; Danielle Blake
Journal:  J Nat Prod       Date:  2003-08       Impact factor: 4.050

Review 2.  Records of usage or assays in Phyllanthus (Euphorbiaceae). I. Subgenera Isocladus, Kirganelia, Cicca and Emblica.

Authors:  D W Unander; G L Webster; B S Blumberg
Journal:  J Ethnopharmacol       Date:  1990-10       Impact factor: 4.360

Review 3.  Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Authors:  Michael B Atkins; Marc S Ernstoff; Robert A Figlin; Keith T Flaherty; Daniel J George; William G Kaelin; Eugene D Kwon; Towia A Libermann; W Marston Linehan; David F McDermott; Augusto C Ochoa; Allan J Pantuck; Brian I Rini; Mark A Rosen; Jeffrey A Sosman; Vikas P Sukhatme; Johannes W Vieweg; Christopher G Wood; Laura King
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 4.  Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation. II. The subgenus Phyllanthus.

Authors:  D W Unander; G L Webster; B S Blumberg
Journal:  J Ethnopharmacol       Date:  1991-09       Impact factor: 4.360

5.  Pleuromutilins. Fermentation, structure and biosynthesis.

Authors:  F Knauseder; E Brandl
Journal:  J Antibiot (Tokyo)       Date:  1976-02       Impact factor: 2.649

6.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

Authors:  K D Paull; R H Shoemaker; L Hodes; A Monks; D A Scudiero; L Rubinstein; J Plowman; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

7.  Ethylene glycol toxicity.

Authors:  K E Bove
Journal:  Am J Clin Pathol       Date:  1966-01       Impact factor: 2.493

Review 8.  Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review.

Authors:  G Bagalkotkar; S R Sagineedu; M S Saad; J Stanslas
Journal:  J Pharm Pharmacol       Date:  2006-12       Impact factor: 3.765

9.  Ecdysteroids from the caribbean sponge Iotrochota birotulata.

Authors:  V Costantino; C Dell'Aversano; E Fattorusso; A Mangoni
Journal:  Steroids       Date:  2000-03       Impact factor: 2.668

10.  Guaiane-type sesquiterpenoids from Alisma orientalis.

Authors:  Guo-Ping Peng; Gang Tian; Xian-Feng Huang; Feng-Chang Lou
Journal:  Phytochemistry       Date:  2003-08       Impact factor: 4.072

View more
  62 in total

1.  Total synthesis: towards artificial terpene cyclases.

Authors:  Matthieu Willot; Mathias Christmann
Journal:  Nat Chem       Date:  2010-07       Impact factor: 24.427

2.  Chlorinated englerins with selective inhibition of renal cancer cell growth.

Authors:  Rhone K Akee; Tanya Ransom; Ranjala Ratnayake; James B McMahon; John A Beutler
Journal:  J Nat Prod       Date:  2012-01-26       Impact factor: 4.050

3.  Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.

Authors:  Corena V Grant; Chase M Carver; Shayne D Hastings; Karthik Ramachandran; Madesh Muniswamy; April L Risinger; John A Beutler; Susan L Mooberry
Journal:  Breast Cancer Res Treat       Date:  2019-06-22       Impact factor: 4.872

4.  Molecular Scaffold Hopping via Holistic Molecular Representation.

Authors:  Francesca Grisoni; Gisbert Schneider
Journal:  Methods Mol Biol       Date:  2021

5.  Importance of a 4-Alkyl Substituent for Activity in the Englerin Series.

Authors:  Daniel C Elliott; John A Beutler; Kathlyn A Parker
Journal:  ACS Med Chem Lett       Date:  2017-06-06       Impact factor: 4.345

Review 6.  Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products.

Authors:  Zachary G Brill; Matthew L Condakes; Chi P Ting; Thomas J Maimone
Journal:  Chem Rev       Date:  2017-03-15       Impact factor: 60.622

7.  Catalytic Enantioselective Intermolecular [5 + 2] Dipolar Cycloadditions of a 3-Hydroxy-4-pyrone-Derived Oxidopyrylium Ylide.

Authors:  Katherine N Fuhr; Danielle R Hirsch; Ryan P Murelli; Stacey E Brenner-Moyer
Journal:  Org Lett       Date:  2017-11-17       Impact factor: 6.005

8.  Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-(ω-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines.

Authors:  Michele Tonelli; Bruno Tasso; Lorenzo Mina; Giuseppe Paglietti; Vito Boido; Fabio Sparatore
Journal:  Mol Divers       Date:  2013-04-13       Impact factor: 2.943

9.  Oxidopyrylium [5+2] Cycloaddition Chemistry: Historical Perspective and Recent Advances (2008-2018).

Authors:  Lauren P Bejcek; Ryan P Murelli
Journal:  Tetrahedron       Date:  2018-04-05       Impact factor: 2.457

Review 10.  A continuum of progress: applications of N-hetereocyclic carbene catalysis in total synthesis.

Authors:  Javier Izquierdo; Gerri E Hutson; Daniel T Cohen; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-16       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.